Related Experiment Video
Updated: Jun 22, 2026

09:52
Non-invasive Optical Imaging of the Lymphatic Vasculature of a Mouse
Published on: March 8, 2013
16.1K
Characterizing Normal Upper Extremity Lymphatic Flow with 99mTc In-House Dextran: A Retrospective Study
Wiroj Katiyarangsan1,2, Putthiporn Charoenphun1,3, Krisanat Chuamsaamarkkee1,3
1Division of Nuclear Medicine, Department of Diagnostic and Therapeutic Radiology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.
Diagnostics (Basel, Switzerland)
|September 14, 2024
Summary
This study characterizes normal upper extremity lymphatic drainage using technetium-99m in-house Dextran. It reveals typical visualization times and axillary lymph node detection rates for improved clinical diagnosis.
Area of Science:
- Nuclear Medicine
- Radiopharmacy
- Anatomy
Background:
- Lymphoscintigraphy is crucial for evaluating lymphatic system disorders.
- Radiocolloid particle size influences distribution and imaging timing.
- Normal upper extremity lymphatic drainage patterns require detailed characterization.
Purpose of the Study:
- To characterize normal lymphatic drainage patterns of the upper extremity.
- To establish imaging timelines for technetium-99m in-house Dextran lymphoscintigraphy.
- To assess sentinel lymph node visualization and clearance kinetics.
Main Methods:
- Retrospective analysis of 84 upper extremity lymphoscintigraphies (2008-2021).
- Intradermal injection of 99mTc in-house Dextran into both hands.
- Whole-body imaging at intervals up to 60 minutes and delayed imaging.
Main Results:
- 92% lymphatic tract visualization within 45 minutes.
- Axillary lymph node detection increased from 46% at ≤15 min to 86% at 46-60 min.
- Epitrochlear/brachial node visualization was rare (4%); hepatic, renal, and bladder activity common.
Conclusions:
- This study provides a detailed map of normal upper extremity lymphatic drainage using 99mTc in-house Dextran.
- Established timelines aid in interpreting lymphoscintigraphy for conditions like lymphedema.
- Findings support the clinical utility of 99mTc in-house Dextran for lymphatic imaging.

